Insulet Corp. (PODD)
145.63
-2.53
(-1.71%)
USD |
NASDAQ |
Aug 24, 16:00
145.50
-0.13
(-0.09%)
After-Hours: 20:00
Insulet Debt to Equity Ratio : 0.6669 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.6669 |
| March 31, 2026 | 0.7279 |
| December 31, 2025 | 0.6612 |
| September 30, 2025 | 0.7451 |
| June 30, 2025 | 0.9689 |
| March 31, 2025 | 1.274 |
| December 31, 2024 | 1.174 |
| September 30, 2024 | 1.251 |
| June 30, 2024 | 1.40 |
| March 31, 2024 | 1.772 |
| December 31, 2023 | 1.977 |
| September 30, 2023 | 2.338 |
| June 30, 2023 | 2.524 |
| March 31, 2023 | 2.778 |
| December 31, 2022 | 3.008 |
| September 30, 2022 | 3.287 |
| June 30, 2022 | 3.342 |
| March 31, 2022 | 3.170 |
| December 31, 2021 | 2.313 |
| September 30, 2021 | 2.583 |
| June 30, 2021 | 2.736 |
| March 31, 2021 | 1.824 |
| December 31, 2020 | 1.783 |
| September 30, 2020 | 1.549 |
| June 30, 2020 | 1.616 |
| Date | Value |
|---|---|
| March 31, 2020 | 15.24 |
| December 31, 2019 | 11.94 |
| September 30, 2019 | 6.639 |
| June 30, 2019 | 2.471 |
| March 31, 2019 | 2.727 |
| December 31, 2018 | 2.791 |
| September 30, 2018 | 2.953 |
| June 30, 2018 | 3.222 |
| March 31, 2018 | 3.361 |
| December 31, 2017 | 3.572 |
| September 30, 2017 | 4.646 |
| June 30, 2017 | 5.266 |
| March 31, 2017 | 5.296 |
| December 31, 2016 | 5.274 |
| September 30, 2016 | 5.070 |
| June 30, 2016 | 6.486 |
| March 31, 2016 | 6.748 |
| December 31, 2015 | 5.212 |
| September 30, 2015 | 3.282 |
| June 30, 2015 | 2.573 |
| March 31, 2015 | 2.236 |
| December 31, 2014 | 2.083 |
| September 30, 2014 | 2.172 |
| June 30, 2014 | 2.587 |
| March 31, 2014 | 1.010 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Abbott Laboratories | 0.638 |
| DexCom, Inc. | 0.5335 |
| Boston Scientific Corp. | 0.5064 |
| PROCEPT BioRobotics Corp. | 0.2279 |
| Globus Medical, Inc. | 0.0235 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 3.165B |
| Total Liabilities (Quarterly) | 1.743B |
| Shareholders Equity (Quarterly) | 1.422B |
| Current Ratio | 2.448 |
| Net Debt Paydown Yield | 1.41% |